May 19, 2021
FDA approves Apic Bio’s APB-102 for SOD1 Amyotrophic lateral sclerosis
Apic Bio, Inc. today announced that the US FDA had cleared its IND application for APB-102 to treat ...
July 22, 2021
Bluebird bio Receives EC Approval for SKYSONA™ for Early Cerebral Adrenoleukodystrophy (CALD)
Bluebird bio, Inc. today announced that The European Commission (EC) had approved SKYSONA™ (elivaldo ...
July 21, 2025
U.S. FDA Grants Fast Track Designation to Artiva Biotherapeutics’ Lead Program AB-101
Artiva Biotherapeutics, Inc., a clinical-stage company whose mission is to provide highly effective, ...
February 17, 2023
FDA Approves Apellis’ SYFOVRE™ (pegcetacoplan injection) for Geographic Atrophy (GA)
Apellis Pharmaceuticals, Inc. announced today that SYFOVRE™ (pegcetacoplan injection) has been appro ...
July 21, 2025
Biohaven’s Taldefgrobep Alfa Receives Fast Track Designation from FDA for Treating Spinal Muscular Atrophy
Biohaven Ltd. has received Fast Track designation from the U.S. Food and Drug Administration (FDA) f ...